BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, April 29, 2026
Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
Hematologic, BioWorld Science RSS Feed RSS

Lilly claims new uses for LY-203638

June 29, 2000

ZK-807834 effective at lower doses and with less bleeding risk compared to other FXa inhibitors

June 27, 2000

First clinical results reported for TS-943, a new small-molecule antiplatelet agent

June 26, 2000

Corvas completes enrollment for rNAPc2 phase II study

June 26, 2000

Boehringer Ingelheim claims thrombin inhibitor series

June 23, 2000

Antiplatelet compounds in early development at Welfide superior to cilostazol in activity, safety

June 23, 2000

TP receptor antagonist S-18886 shows broad-spectrum antiplatelet effects

June 22, 2000

LY-203638 effective in patients with HIT

June 21, 2000

Thrombotic thrombocytopenic purpura associated with clopidogrel

June 16, 2000

Thrombin inhibitors from Merck reported to have nanomolar inhibitory activity

June 14, 2000
Previous 1 2 … 345 346 347 348 349 350 351 352 353 … 447 448 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 28, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Cerebral aneurysm illustration

    Grace Therapeutics hits CRL setback with GTx-104 despite positive trial

    BioWorld
    Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
  • Epileptic brain and abnormal EEG wave discharges

    Neuro deals aplenty: UCB’s $1B+ takeover of Neurona the latest

    BioWorld
    A flurry of deals focused on the neurological disease space in 2026 suggest large biopharma companies are searching for the next best therapeutics for everything...
  • Gold-encircled handshake

    Pleased to own ya, Kelonia: Lilly’s $7B CAR T deal

    BioWorld
    The already-thriving CAR T space took another big stride forward as Eli Lilly and Co. disclosed its plan to acquire Boston-based Kelonia Therapeutics Inc. for as...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing